We are live on ! Find out more
Barrow, Hanley, Mewhinney & Strauss

Barrow, Hanley, Mewhinney & Strauss Portfolio holdings

AUM $33B
1-Year Est. Return 40.62%
This Fund
S&P 500
This Quarter Est. Return
+5.29%
1 Year Est. Return
+40.62%
3 Year Est. Return
+99.15%
5 Year Est. Return
+129.95%
10 Year Est. Return
+402.57%
AUM
$30B
AUM Growth
-$1.37B
Cap. Flow
-$2.3B
Cap. Flow %
-7.65%
Top 10 Hldgs %
22.73%
Holding
418
New
69
Increased
85
Reduced
118
Closed
51

Top Buys

Rank Stock Value
1
GEHC icon
GE HealthCare
GEHC
+$507M
2
LPLA icon
LPL Financial
LPLA
+$446M
3
HPE icon
Hewlett Packard
HPE
+$425M
4
PCG icon
PG&E
PCG
+$279M
5
UL icon
Unilever
UL
+$276M

Top Sells

Rank Stock Value
1
VRT icon
Vertiv
VRT
+$390M
2
LEN icon
Lennar Class A
LEN
+$368M
3
NICE icon
Nice
NICE
+$334M
4
CIEN icon
Ciena
CIEN
+$327M
5
PM icon
Philip Morris
PM
+$315M

Sector Composition

Rank Sector Weight
1 Financials 19.5%
2 Technology 17.28%
3 Healthcare 11.28%
4 Industrials 8.54%
5 Utilities 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SM icon
251
SM Energy
SM
$8.41B
$6.79K ﹤0.01%
363
REZI icon
252
Resideo Technologies
REZI
$3.02B
$6.57K ﹤0.01%
+187
New +$6.92K
SYNA icon
253
Synaptics
SYNA
$3.74B
$6.51K ﹤0.01%
88
+20
+29% +$1.41K
OI icon
254
O-I Glass
OI
$1.14B
$6.46K ﹤0.01%
438
+1
+0.2% +$13
GFF icon
255
Griffon
GFF
$4.57B
$6.41K ﹤0.01%
87
+23
+36% +$1.71K
PRG icon
256
PROG Holdings
PRG
$1.58B
$6.4K ﹤0.01%
217
CNMD icon
257
CONMED
CNMD
$1.51B
$6.37K ﹤0.01%
157
MLKN icon
258
MillerKnoll
MLKN
$1.59B
$6.11K ﹤0.01%
334
JXN icon
259
Jackson Financial
JXN
$9.05B
$6.08K ﹤0.01%
57
+11
+24% +$1.09K
LZB icon
260
La-Z-Boy
LZB
$1.3B
$6.08K ﹤0.01%
163
UPBD icon
261
Upbound Group
UPBD
$1.13B
$5.88K ﹤0.01%
335
MBC icon
262
MasterBrand
MBC
$1.8B
$5.85K ﹤0.01%
530
+481
+982% +$5.63K
NICE icon
263
Nice
NICE
$5.92B
$5.65K ﹤0.01%
50
-2,768,870
-100% -$334M
ARCB icon
264
ArcBest
ARCB
$3.11B
$5.64K ﹤0.01%
76
+68
+850% +$4.84K
BLMN icon
265
Bloomin' Brands
BLMN
$955M
$5.39K ﹤0.01%
873
SHOO icon
266
Steven Madden
SHOO
$3.3B
$5.37K ﹤0.01%
129
KELYA icon
267
Kelly Services Class A
KELYA
$590M
$5.3K ﹤0.01%
602
VAC icon
268
Marriott Vacations Worldwide
VAC
$3.95B
$5.19K ﹤0.01%
90
+49
+120% +$2.9K
CLB icon
269
Core Laboratories
CLB
$550M
$5.18K ﹤0.01%
323
AVNS
270
DELISTED
Avanos Medical
AVNS
$4.92K ﹤0.01%
438
-186
-30% -$2.13K
EPC icon
271
Edgewell Personal Care
EPC
$1.32B
$4.88K ﹤0.01%
286
BZH icon
272
Beazer Homes USA
BZH
$884M
$4.76K ﹤0.01%
235
CAL icon
273
Caleres
CAL
$440M
$4.75K ﹤0.01%
390
CPRI icon
274
Capri Holdings
CPRI
$1.55B
$4.56K ﹤0.01%
187
+39
+26% +$902
OMCL icon
275
Omnicell
OMCL
$1.53B
$4.53K ﹤0.01%
100

Similar funds

Barrow, Hanley, Mewhinney & Strauss's Q4 2025 Portfolio in Review

As of Q4 2025, Barrow, Hanley, Mewhinney & Strauss held 418 positions worth $30B, down 4.4% from $31.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Barrow, Hanley, Mewhinney & Strauss withdrew a net $2.3B in Q4 2025, closing 51 positions and reducing 118 holdings. Its most notable exit was Las Vegas Sands, an estimated $293M position sold in full.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Barrow, Hanley, Mewhinney & Strauss opened a new position in GE HealthCare worth $534M.

  • Barrow, Hanley, Mewhinney & Strauss's largest Q4 2025 buy was GE HealthCare: 6,506,398 shares worth $534M.
  • Barrow, Hanley, Mewhinney & Strauss added most to PG&E in Q4 2025, an estimated $279M increase.
  • Barrow, Hanley, Mewhinney & Strauss's biggest Q4 2025 reduction was Vertiv, cutting an estimated $390M.
  • Barrow, Hanley, Mewhinney & Strauss fully exited Las Vegas Sands in Q4 2025, selling an estimated $293M.
  • Barrow, Hanley, Mewhinney & Strauss's ten largest holdings make up 23% of its $30B portfolio in Q4 2025.
  • Barrow, Hanley, Mewhinney & Strauss opened 69 new positions and closed 51 in Q4 2025.
  • Barrow, Hanley, Mewhinney & Strauss's portfolio value fell 4.4% quarter-over-quarter to $30B.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q4 2025, filed 11 Feb 2026.